Dialysis vs Transplant Decision Tool

Kidney transplant consistently shows the best long-term survival rates among all renal replacement therapies. Studies show 5-year survival rates of approximately 85-90% for living-donor transplants, compared to 35-45% for dialysis patients. However, eligibility depends on many factors including age, overall health, and donor availability. Discuss with your nephrologist to determine if transplant is suitable for you.

Yes, patients can switch between hemodialysis and peritoneal dialysis in most cases. The transition requires planning and training. For example, moving from in-center HD to PD requires 1-2 weeks of training and surgical placement of a PD catheter. Discuss transition options with your nephrologist who can guide you through the process based on your specific medical situation.

Home hemodialysis is considered safe when patients receive proper training, typically 4-8 weeks. A care partner is recommended but not always required depending on the system used. Modern home HD machines have safety features including air detection, blood leak sensors, and automatic shutoffs. Many patients report feeling more confident managing their own treatment after completing training.

Kidney transplant surgery in India typically costs between ₹5-15 lakhs, depending on the hospital, city, and whether it's a living or deceased donor transplant. Post-transplant immunosuppressive medications cost approximately ₹8,000-15,000 per month. While the initial cost is higher, transplant becomes more cost-effective than dialysis after 2-3 years due to lower ongoing monthly expenses and better quality of life.

Travel is possible on all forms of dialysis but varies by modality. PD offers the most travel flexibility as supplies can be shipped ahead. In-center HD requires arranging guest dialysis at your destination. Home HD depends on machine portability. After a successful transplant, travel freedom is greatest with fewer restrictions. Always plan ahead, carry medical records, and inform your nephrologist before traveling.

The timeline varies significantly. With a living donor (family member or friend), evaluation and surgery can be completed in 2-4 months. For a deceased donor transplant, the wait depends on blood type, antibodies, and availability, often ranging from 2-5 years in India. Pre-emptive transplant (before starting dialysis) is ideal when a living donor is available. Your transplant team will guide the evaluation process.

In-center HD has the strictest diet: limited fluids, potassium, phosphorus, and sodium. PD allows slightly more flexibility due to daily treatment. Home HD (more frequent sessions) offers better clearance and more dietary freedom. Post-transplant patients enjoy the most diet flexibility, though some restrictions on raw/uncooked foods and grapefruit (which interacts with immunosuppressants) apply. Use Dr. Bhatt's Diet Planner tool for personalized guidance.

Neither is universally better; each has advantages depending on patient factors. PD preserves residual kidney function longer, offers more independence, and avoids needle sticks. HD may be preferred for larger patients, those with abdominal issues, or those who prefer supervised treatment. Studies show comparable survival rates in the first 2-3 years. The best modality is the one that fits your lifestyle and medical needs.

If a transplanted kidney fails, patients return to dialysis (HD or PD). Most patients can be listed for a second transplant. The failed kidney is usually left in place unless it causes problems. With modern immunosuppression, first-year graft failure rates are low (around 5-8%), and many transplants function well for 15-20 years. Regular follow-up with your transplant nephrologist is essential for early detection of any issues.

Yes, age alone is not a contraindication for kidney transplant. Many patients over 65 receive successful transplants. The decision depends more on overall health, cardiovascular fitness, and absence of active malignancy than on age. Older recipients may benefit from less aggressive immunosuppression protocols. Evaluation includes cardiac testing, cancer screening, and functional assessment to determine transplant suitability.